financetom
Business
financetom
/
Business
/
Crusoe secures $600 million in Series D round led by Founders Fund
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crusoe secures $600 million in Series D round led by Founders Fund
Dec 12, 2024 9:31 AM

Dec 12 (Reuters) - Crusoe has raised $600 million in a

Series D funding round led by venture capital firm Founders

Fund, the artificial intelligence infrastructure provider said

on Thursday.

The new fundraise valued Crusoe at $2.8 billion. Other

investors in the round included Fidelity, Long Journey Ventures,

the United Arab Emirates sovereign wealth fund Mubadala, Nvidia ( NVDA )

, Ribbit Capital and Valor Equity Partners, the company

said.

The latest fundraising will be used to invest in the

expansion and growth of data centers and the Crusoe cloud, the

startup said.

The rapid evolution of cloud computing and data centers,

driven by generative AI, underscores the growing importance of

AI infrastructure providers such as Crusoe, Lambda and

CoreWeave.

These companies integrate graphics processing units and

other tools into their infrastructure to assist enterprises in

managing their AI workloads effectively.

Crusoe, which was launched in 2018 as a cryptocurrency

business, pivoted to building computing and AI infrastructure

using large-scale clean energy.

Over the past year, Crusoe has expanded its collaboration

with chipmaker Nvidia ( NVDA ), consulting firm Deloitte

and computing infrastructure provider VAST Data, among

others.

The company has introduced Crusoe Cloud, a new cloud

platform aimed at helping developers and data scientists manage

AI and machine learning workloads efficiently.

Investors are rushing to support startups capitalizing on

the generative AI boom.

Last week, AI firm Nebius Group said it was raising $700

million in a private placement from investors, including Nvidia ( NVDA ),

to build tools for AI developers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
May 25, 2026
SAN FRANCISCO, May 25, 2026 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. ( IBRX ) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio ( IBRX ) securities between January 19, 2026 and March 24, 2026. The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by...
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
May 25, 2026
10:31 AM EDT, 05/25/2026 (MT Newswires) -- WonderFi Technologies' ( WONDF ) wholly-owned subsidiary, Coinsquare Capital Markets Ltd (CCML), received regulatory approval from the Canadian Investment Regulatory Organization (CIRO) for Robinhood Markets, Inc's previously announced acquisition of WonderFi ( WONDF ) pursuant to a statutory plan of arrangement under the Business Corporations Act (British Columbia), the company said on Monday....
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
May 25, 2026
11:14 AM EDT, 05/25/2026 (MT Newswires) -- PharmaCorp Rx (PCRX.V), up 10.4% on last look, is acquiring a PharmaChoice Canada-bannered pharmacy in Morrisburg, Ontario, for $8.2 million, the company said on Monday. PharmaCorp had executed letters of intent earlier this year regarding four additional pharmacy acquisitions. The Morrisburg pharmacy is the first conversion of the LOIs into a share purchase...
Atlas Engineered Products Q1 Loss Widens
Atlas Engineered Products Q1 Loss Widens
May 25, 2026
10:39 AM EDT, 05/25/2026 (MT Newswires) -- Atlas Engineered Products ( APEUF ) , down 3% on last look, said on Monday that first-quarter net loss widened as revenue fell. Net loss for the quarter ended March 31, widened to $1.73 million, or $0.02 per diluted share, from a loss of $0.85 million, or $0.01 per diluted share, in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved